Pharmaceutical Business Review
Return to: PBR Home
Top Headlines

Pharmaceutical Business Review

Kite, Sangamo form $3bn cancer cell therapy collaboration Gilead Sciences’ subsidiary Kite has agreed to use Sangamo Therapeutics’ zinc finger nuclease (ZFN) technology platform to develop cancer treatments in a collaboration deal worth over $3bn. Drug Research > Drug Discovery & Development > News
BenevolentAI buys drug discovery and development facility in Cambridge, UK BenevolentAI has acquired an advanced drug discovery and development facility on the Babraham Research Campus in Cambridge, UK, for an undisclosed sum.
Drug Research > Drug Discovery & Development > News New collaborative project to develop Zika virus vaccine for pregnant women A new collaborative project has been launched to develop a Zika virus vaccine that is suitable for use in pregnancy.
Drug Research > Drug Discovery & Development > News Kite, Sangamo form $3bn cancer cell therapy collaboration By PBR Staff Writer
Gilead Sciences’ subsidiary Kite has agreed to use Sangamo Therapeutics’ zinc finger nuclease (ZFN) technology platform to develop cancer treatments in a collaboration deal worth over $3bn.
Drug Research > Drug Discovery & Development > News
Emulate, Roche partner to apply organ-chips to drug efficacy and safety By PBR Staff Writer
Scientists from Emulate and Roche have partnered to use Organ-Chips for testing of efficacy and safety of new antibody therapeutics and combination therapies.
Drug Research > Drug Discovery & Development > News ATUM, Just Biotherapeutics collaborate to speed up drug discovery ATUM has signed a patent licensing agreement, which gives Just Biotherapeutics access to its Leap-In cell line development tools.
Drug Research > Drug Discovery & Development > News FDA accepts Acorda’s NDA for orally inhaled levodopa therapy Inbrija The US Food and Drug Administration (FDA) has accepted for filing Acorda Therapeutics' new drug application (NDA) for Inbrija (levodopa inhalation powder).
Regulatory Affairs > News

Latest News and Insight by Sector

Production & Manufacturing

Vertex’s Symdeko cystic fibrosis drug secures FDA approval
By PBR Staff Writer
Vertex Pharmaceuticals’ Symdeko (tezacaftor/ivacaftor and ivacaftor) has been approved in the US to treat the underlying cause of cystic fibrosis (CF) in people aged 12 and over.
Regulatory Affairs > News
ViiV Healthcare sues Gilead over HIV drug patent infringement
By PBR Staff Writer
ViiV Healthcare has filed a lawsuit against Gilead Sciences alleging that bictegravir contained in the latter’s triple combination HIV drug infringes patent covering dolutegravir in the US and Canada.
Regulatory Affairs > News

Drug Research

BenevolentAI buys drug discovery and development facility in Cambridge, UK
BenevolentAI has acquired an advanced drug discovery and development facility on the Babraham Research Campus in Cambridge, UK, for an undisclosed sum.
Drug Research > Drug Discovery & Development > News
New collaborative project to develop Zika virus vaccine for pregnant women
A new collaborative project has been launched to develop a Zika virus vaccine that is suitable for use in pregnancy.
Drug Research > Drug Discovery & Development > News

Inward Investment

New WuXi Life Science to acquire WuXi PharmaTech for $3.3bn
Shanghai-based WuXi PharmaTech has entered into a merger agreement with New WuXi Life Science and its wholly owned subsidiary WuXi Merger, worth a total cash consideration of $3.3bn.
Inward Investment > News
PPF Group acquires minority stake in Cytune Pharma
By PBR Staff Writer
PPF Group, in cooperation with SOTIO has completed acquisition of minority stake in French biotechnology firm Cytune Pharma.
Inward Investment > News

Packaging

Catalent completes acquisition of Australia's Pharmapak
By PBR Staff Writer
US-based Catalent Pharma Solutions has strengthened its ability to provide integrated solutions to customers with the acquisition of Pharmapak Technologies, an Australian pharmaceutical packaging business.
Production & Manufacturing > OTC > News
MP Global Products introduces foam-free packaging for shipment of temperature sensitive pharmaceuticals
MP Global Thermal Packaging Products insulated protective mailers and box liners are specifically designed for temperature control and protection of mail order shipments of temperature sensitive pharma, pet meds, and natural and organic cosmetics.
Packaging > News

Contract Research & Services

Orano Med, RadioMedix recruit first patients in AlphaMedix phase 1 clinical trial
Orano Med and RadioMedix have recruited first three patients in the AlphaMedix phase 1 clinical trial.
Contract Research & Services > Clinical Trials > News
Sterna reports positive results in severe ulcerative colitis drug trial
By PBR Staff Writer
sterna biological has reported positive results from the SECURE study, a Phase 2a trial in patients with moderate to severe ulcerative colitis treated with its GATA-3 specific DNAzyme formulation SB012.
Contract Research & Services > Clinical Trials > News

Automation

Horizon Discovery out-licenses cell line engineering technology to US firm
Horizon Discovery Group has entered into a non-exclusive out-licensing agreement with an undisclosed US-based immuno-oncology company (the Partner) for its technologies to support the development and manufacture of a biomanufacturing cell line for commercial use.
Automation > IT & Software > News
GE to provide biomanufacturing platform for Clover’s Chinese facility
By PBR Staff Writer
GE Healthcare will provide its biomanufacturing platform for Clover Biopharmaceuticals’ new production facility in China.
Automation > IT & Software > News

Regulatory Affairs

FDA accepts Acorda’s NDA for orally inhaled levodopa therapy Inbrija
The US Food and Drug Administration (FDA) has accepted for filing Acorda Therapeutics' new drug application (NDA) for Inbrija (levodopa inhalation powder).
Regulatory Affairs > News
Mylan bags FDA’s tentative approval for fixed-dose HIV combo therapy
By PBR Staff Writer
Mylan has secured tentative approval from the US Food and Drug Administration (FDA) for its fixed-dose HIV combination therapy Dolutegravir/Emtricitabine/Tenofovir Alafenamide (DTG/FTC/TAF 50 mg/200mg/25mg) tablets.
Regulatory Affairs > News



Data-Label.co.uk DataLabel have been supplying
the medical industry with labels
for over 10 years

Manufactures of
healthcare packaging
machinery